Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Aug 11, 2025

Accession no.
0001628280-25-039404
Filed
Aug 11, 2025
Trade date
Jul 1-31, 2025
Filing delay
41 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 22 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.17K. It was filed 41 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 1, 2025Common StockPPurchaseAcquired+16$3.56+$56.9643,352Direct
Jul 2, 2025Common StockPPurchaseAcquired+16$3.52+$56.3243,368Direct
Jul 3, 2025Common StockPPurchaseAcquired+16$3.31+$52.9643,384Direct
Jul 7, 2025Common StockPPurchaseAcquired+16$3.23+$51.6843,400Direct
Jul 8, 2025Common StockPPurchaseAcquired+16$3.06+$48.9643,416Direct
Jul 9, 2025Common StockPPurchaseAcquired+16$3.05+$48.843,432Direct
Jul 10, 2025Common StockPPurchaseAcquired+16$3.20+$51.243,448Direct
Jul 11, 2025Common StockPPurchaseAcquired+16$3.21+$51.3643,464Direct
Jul 14, 2025Common StockPPurchaseAcquired+16$3.46+$55.3643,480Direct
Jul 15, 2025Common StockPPurchaseAcquired+16$3.45+$55.243,496Direct
Jul 16, 2025Common StockPPurchaseAcquired+16$3.79+$60.6443,512Direct
Jul 17, 2025Common StockPPurchaseAcquired+16$3.82+$61.1243,528Direct
Jul 18, 2025Common StockPPurchaseAcquired+16$3.59+$57.4443,544Direct
Jul 21, 2025Common StockPPurchaseAcquired+16$3.45+$55.243,560Direct
Jul 22, 2025Common StockPPurchaseAcquired+16$3.47+$55.5243,576Direct
Jul 23, 2025Common StockPPurchaseAcquired+16$3.54+$56.6443,592Direct
Jul 24, 2025Common StockPPurchaseAcquired+16$3.55+$56.843,608Direct
Jul 25, 2025Common StockPPurchaseAcquired+16$3.37+$53.9243,624Direct
Jul 28, 2025Common StockPPurchaseAcquired+13$3.47+$45.1143,637Direct
Jul 29, 2025Common StockPPurchaseAcquired+13$3.33+$43.2943,650Direct
Jul 30, 2025Common StockPPurchaseAcquired+13$3.55+$46.1543,663Direct
Jul 31, 2025Common StockPPurchaseAcquired+13$3.50+$45.543,676Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)